Warning:
Do not launch ANY of the links while your are in create or edit mode. There is a good chance all of your work will be gone.
Template Usage Information:
- Submit template change requests to PMO@HL7.org
- For Reaffirmations, please refer to the FAQ in Hl7 Project Scope Statement Instructions for a list of which sections and fields should be completed
Project Name and ID
Enter the name of the project here: FHIR Quality Measure Implementation Guide | ||||||||||
Project ID: | 1499 | |||||||||
Complete this section for all “Direct to Normative” ballot projects and when a project proceeds from “Informative to Normative” or “STU to Normative”. Forward PSS to the TSC (via tscpm@HL7.org); this triggers American National Standards Institute (ANSI) Project Initiation Notification (PINS) submission. | ||||||||||
| TSC Notification: Informative/STU to Normative | Date: Submission date | ||||||||
| - or - Direct to Normative (no STU) (includes reaffirmations) |
| ||||||||
Identify ISO, IEC or ISO/IEC standard to be adopted in text box below | ||||||||||
Enter info here if an ISO, IEC, or ISO/IEC Standard is to be adopted as an American National Standard; Enter the designation of the standard(s) to be adopted: | ||||||||||
Includes text from ISO, IEC or ISO/IEC standard: Check here if this standard includes excerpted text from one or more ISO, IEC or ISO/IEC standards, but is not an identical or modified adoption. | Yes |
| No | |||||||
Select the unit of measure used in the standard; if no measurements are in the standard, select N/A |
| N/A |
| U.S. | Metric |
| Both | |||
| Investigative Project (aka PSS-Lite) | Date : | ||||||||
Check this box when the project is investigative or exploratory in nature, which allows limited project scope definition. Sections 1-Project Name, 2-Sponsoring Group(s)/Project Team, 3a-Project Scope, 3b-Project Need, 3e-Project Objectives/Deliverables/Target Dates, 3i-Project Document Repository, 6b-[Realm, if known], and 6d-[applicable Approval Dates] are required for Investigative Project. Investigative Project specific instructions are highlighted in yellow. An investigative project must advance in two WGM cycles, requiring a full scope statement. Otherwise the project will be closed. |
2. Sponsoring Group(s) / Project Team
2.a. Primary Sponsor/Work Group
Primary Sponsor/Work Group | Clinical Quality Information |
2.b. Co-sponsor Work Group(s)
Co-sponsor Work Group(s): (Enter co-sponsor approval dates in Section 6.d Project Approval Dates) | Clinical Decision Support | |
Indicate the level of involvement that the co-sponsor will have for this project: | ||
Request formal content review prior to ballot | ||
x | Request periodic project updates. Specify period | WGMs |
Other Involvement. Specify details here: |
2.c. Project Team
All names should have confirmed their role in the project prior to submission to the TSC.
Project facilitator (1Mandatory) | Bryn Rhodes, Rob Samples |
Other interested parties and their roles | Paul Denning (MITRE) |
Multi-disciplinary project team (recommended) | |
Modeling facilitator | Bryn Rhodes |
Publishing facilitator | Bryn Rhodes |
Vocabulary facilitator | Rob McClure |
Domain expert rep | Floyd Eisenberg, Lisa Anderson, Claudia Hall, Patty Craig, Anne Smith |
Business requirement analyst | Floyd Eisenberg, Lisa Anderson, Claudia Hall, Patty Craig, Anne Smith |
Conformance facilitator (for IG projects) | Bryn Rhodes |
Other facilitators (SOA, etc) | |
Implementers (2Mandatory for STU projects) FHIR Project Note: The implementer requirement will be handled by the “balloting” project. Therefore work groups do not fill out the above section. However, feel free to list implementers specific to your work group’s resources if you know of any. | |
1) National Committee for Quality Assurance, 2) Medisolv, 3) MITRE | |
3. Project Definition
3.a. Project Scope
The Institute of Medicine (IOM) defines quality as: “The degree to which health services for individuals and populations increase the likelihood of desired health outcomes and are consistent with current professional knowledge.” [1] For care quality to be evaluated, it must be standardized and communicated to the appropriate organizations. To that end, this Implementation Guide will be written to provide guidance for authoring electronic Clinical Quality Measures (eCQMs) utilizing the following standards:
The requirements were established by experience and implementations of eCQMs using existing HL7 V3 standards:
|
3.b. Project Need
FHIR Clinical Reasoning provides infrastructure requirements for representing a health quality measure as an electronic format. A quality measure is a quantitative tool to assess the performance of an individual or organization’s performance in relation to a specified process or outcome via the measurement of an action, process, or outcome of clinical care. Quality measures are often derived from clinical guidelines and are designed to determine whether the appropriate care has been provided given a set of clinical criteria and an evidence base. FHIR Clinical Reasoning defines the components for classification and management of the quality measure as well as important metadata and sections that also define the specific elements that carry the content of the quality measure. Through standardization of a measure’s structure, metadata, definitions, and logic, FHIR Clinical Reasoning ensures measure consistency and unambiguous interpretation. A health quality measure encoded in this format is referred to as an electronic clinical quality measure (eCQM). Standardization of document structure (e.g., sections), metadata (e.g., author, verifier), and definitions (e.g., numerator, initial population) enable a wide range of measures currently existing in a variety of formats to achieve consistency. This formal representation of the clinical, financial, and administrative concepts and logic within an eCQM produce unambiguous interpretation and consistent reporting. This implementation guide (IG) provides specific guidance to eCQM developers and implementers to assure consistency for applying CQL expressions using any data model, enhancing ability to share eCQM artifacts for direct implementation and calculation. The IG will provide examples using the US Realm FHIR QICore data model but it will not restrict usage of any data model and, therefore, it is relevant for Universal Realm. |
3.c. Security Risks
Will this project produce executable(s), for example, schemas, transforms, style sheets, executable program, etc. If so the project must review and document security risks. Refer to the Cookbook for Security Considerations for additional guidance, including sample spreadsheets that may be used to conduct the security risk assessment. | Yes | |
X | No | |
Unknown |
3.d. External Drivers
The project will support existing efforts by health plans, eCQM developers and EHR implementers to express and process eCQMs using FHIR to measure clinical performance. National Committee for Quality Assurance (NCQA) has prototyped Healthcare Effectiveness Data and Information Set (HEDIS) measures as eCQMs using FHIR starting in 2018 and this IG will support standardization. US governmental agencies (e.g., Centers for Medicare and Medicaid Services (CMS)) are considering transitioning eCQMs from existing HQMF and CQL-based HQMF standards to FHIR. While CMS has not made a decision to move the process to FHIR and there is no established date for such a transition, the FHIR-based eCQM IG will support necessary testing to provide sufficient evidence to support any such future decisions. |
3.e. Project Objectives / Deliverables / Target Dates
Within each row, enter the explicit work product(s) / objective(s). Indicate their target date at the right in WGM/Ballot Cycle format. Include the project end date as the last objective (for standards projects, the end date will be the projected ANSI approval date). | Target Date(in WGM or ballot cycle format, e.g. ‘2017 Sept WGM’ or ‘2017 Jan Ballot’) |
Enter objective/deliverable here. All planned ballots and their target dates should be included The example below is a "STU to Normative" path | Enter Target Date |
FHIR Connectathon Testing (initiated in several cycles starting with May 2016) | May 2016 FHIR Connectathon and every FHIR Connectathon since then Digital Quality Summit 2017 and 2018 MiHIN Connectathon 2017 |
1st STU Ballot | 2019 May Ballot |
Complete 1st STU Ballot Reconciliation | 2019 May WGM |
Request 1st STU Publication | 2019 Sep WGM |
1st STU Period – 12 months | 2019 Sep - 2020 Sep |
2nd STU Ballot | 2020 Sep Ballot |
Complete 2nd STU Ballot Reconciliation | 2020 Sep WGM |
Request 2nd STU Publication | 2021 Jan WGM |
2nd STU Period - 12 months | 2021 Jan - 2022 Jan |
Additional STU cycles as needed | as needed |
Normative Ballot | 2022 Jan Ballot |
Complete Normative Ballot Reconciliation | 2022 May WGM |
Submit Publication Request Normative Version | 2022 Sep WGM |
Receive ANSI Approval | 2023 Jan WGM |
Project End Date (All objectives have been met) | 2023 Jan WGM |
3.f. Common Names / Keywords / Aliases
What common name does your group use to refer to the product(s) produced? What alternative names, aliases and keywords does your group use to refer to the product(s) that will be produced? |
3.g. Lineage
If your project creates a Post-Release 1 version; indicate the name of the prior product and if it is supplanting, replacing or coexisting with a previous release: No prior FHIR eCQM IG, however, the IG is based on experience gained from implementation of:
|
3.h. Project Dependencies
Enter any dependencies or the name & Project Insight ID of project(s) that this project is dependent upon to achieve its objectives: FHIR CQL Projects and their Project Insight IDs can be found via http://www.hl7.org/special/Committees/projman/searchableProjectIndex.cfm?ref=common |
3.i. HL7-Managed Project Document Repository Location
Projects must adhere to the TSC's guidelines (which were approved on 2016-04-04 and summarized in Appendix A). A template to create a Project Page on the HL7 Wiki is available at: http://wiki.hl7.org/index.php?title=Template:Project_Page. |
Enter the SPECIFIC URL of the HL7-MANAGED SITE where supporting project documents, deliverables, ballot reconciliation work and other project information will be kept. |
(To be determined) |
3.j. Backwards Compatibility
Are the items being produced by this project backward compatible? | Yes | No | Unknown | X | N/A | |||
If you check 'Yes' please indicate the earliest prior release and/or version to which the compatibility applies: | ||||||||
For V3, are you using the current data types? (Refer to TSC position statement on new projects using R2B for more information on the current V3 data types) | Yes | No | Unknown | X | N/A | |||
If you check no, please explain the reason: | ||||||||
If desired, enter additional information regarding Backwards Compatibility. |
3.k. External Vocabularies
Will this project include/reference external vocabularies? | Yes | No | X | Unknown | N/A | |||
If Yes, please enter the vocabularies: |
4. Products (check all that apply)
Arden Syntax | V2 Messages – Administrative | ||
Clinical Information Modeling Initiative (CIMI) | V2 Messages - Clinical | ||
Clinical Context Object Workgroup (CCOW) | V2 Messages - Departmental | ||
Domain Analysis Model (DAM) | V2 Messages – Infrastructure | ||
Electronic Health Record (EHR) Functional Profile | V3 Domain Information Model (DIM / DMIM) | ||
FHIR Extensions | V3 Documents – Administrative (e.g. SPL) | ||
X | FHIR Implementation Guide (enter FHIR product version below) | V3 Documents – Clinical (e.g. CDA) | |
FHIR Profiles (enter FHIR product version below) | V3 Documents - Knowledge | ||
FHIR Resources | V3 Foundation – RIM | ||
Guidance (e.g. Companion Guide, Cookbook, etc) | V3 Foundation – Vocab Domains & Value Sets | ||
Logical Model | V3 Messages - Administrative | ||
New/Modified/HL7 Policy/Procedure/Process | V3 Messages - Clinical | ||
New Product Definition (please define below) | V3 Messages - Departmental | ||
New Product Family (please define below) | V3 Messages - Infrastructure | ||
Non Product Project - (Educ. Marketing, Elec. Services, etc.) | V3 Rules - GELLO | ||
White Paper | V3 Services – Java Services (ITS Work Group) | ||
Creating/Using a tool not listed in the HL7 Tool Inventory | V3 Services – Web Services (SOA) |
If you checked New Product Definition or New Product Family, please define below: |
For FHIR IGs and FHIR Profiles, what product version(s) will the profiles apply to? R4 and STU3 and R5 |
5. Project Intent (check all that apply)
Create new standard | Supplement to a current standard | ||||||||
Revise current standard (see text box below) | X | Implementation Guide (IG) will be created/modified | |||||||
Reaffirmation of a standard | Project is adopting/endorsing an externally developed IG: | ||||||||
New/Modified HL7 Policy/Procedure/Process | Specify external organization in Sec. 6 below; | ||||||||
Externally developed IG is to be (select one): | |||||||||
White Paper (select one): | Adopted - OR - | ? | Endorsed | ||||||
Balloted Informative OR | Non-balloted WG White Paper | N/A (Project not directly related to an HL7 Standard) | |||||||
If revising a current standard, indicate the following: | |
- Name of the standard being revised: | NA |
- Date it was published (or request for publication, or ANSI designation date) | |
- Rationale for revision | |
- The relationship between the new standard and the current standard (is it designed to replace the current standard, a supplement to the current standard, etc.) |
5.a. Ballot Type (check all that apply)
Comment (aka Comment-Only) | Joint Ballot (with other SDOs) | |||||
Informative | N/A (project won’t go through ballot) | |||||
X | STU to Normative - OR - | Normative (no STU) | ||||
If necessary, add any additional ballot information here. If artifacts will be jointly balloted with other SDOs, list the other groups. |
5.b. Joint Copyright
Check this box if you will be pursuing a joint copyright. Note that when this box is checked, a Joint Copyright Letter of Agreement must be submitted to the TSC in order for the PSS to receive TSC approval.
Joint Copyrighted Material will be produced? | Yes | X | No |
6. Project Logistics
6.a. External Project Collaboration
Include SDOs or other external entities you are collaborating with, including government agencies as well as any industry outreach. Indicate the nature and status of the Memorandum of Understanding (MOU) if applicable. | ||||
For projects that have some of their content already developed: Not Applicable | ||||
How much content for this project is already developed? | ||||
Was the content externally developed ? : | Y/N | |||
Is this a hosted (externally funded) project? (not asking for amount just if funded) | Yes | No |
6.b. Realm
Universal | - OR - | Realm Specific - U.S. Note, the content will not restrict to USRealm but there are currently no international participants. Hence, the USRealm Steering Committee recommended USRealm until international participation is assured. | ||
| Check here if this standard balloted or was previously approved as realm specific standard | |||
Enter “U.S.” or name of HL7 affiliate(s) here. Provide explanation/justification of realm selection. For projects producing deliverables applicable to multiple realms, document those details here. For Investigative projects, indicate if the project is planned to be Realm Specific or Universal, if known. Work Groups are encouraged designating project a Universal project initially, and discover which Realms can contribute to the work effort during the discovery phase of the project. Note: This status is subject to change during the investigative process. |
6.c. Stakeholders / Vendors / Providers
This section must be completed for projects containing items expected to be ANSI approved, as it is an ANSI requirement for all ballots
| Stakeholders |
| Vendors |
| Providers | |
| Clinical and Public Health Laboratories |
| Pharmaceutical |
| Clinical and Public Health Laboratories | |
| Immunization Registries | X | EHR, PHR |
| Emergency Services | |
X | Quality Reporting Agencies |
| Equipment | X | Local and State Departments of Health | |
X | Regulatory Agency | X | Health Care IT |
| Medical Imaging Service | |
| Standards Development Organizations (SDOs) |
| Clinical Decision Support Systems | X | Healthcare Institutions (hospitals, long term care, home care, mental health) | |
X | Payors |
| Lab |
| Other (specify in text box below) | |
X | Other (specify in text box below) | X | HIS |
| N/A | |
| N/A |
| Other (specify below) |
| ||
|
| N/A |
|
| ||
Other: Indicate other stakeholders, vendors or providers not listed above. Quality Measure Development Organizations, Clinical Professional Societies | ||||||
6.d. Project Approval Dates
Click here to go to HL7 Project Scope Statement Instructions#Appendix A for more information regarding this section.
Approvals are by simple majority vote of the approving body
Sponsoring Work Group Approval Date: | Clinical Quality Information | 2019-01-14 Mon Q2 WGM Minutes | ||||||||||||||
Administrative review – in parallel with Work Group Approva | ||||||||||||||||
Co-Sponsor Group Approval Date | Clinical Decision Support | 2019-01-16 in joint meeting with CQI Wed Q2 WGM Minutes | ||||||||||||||
Family Management Group Approval Date(s) | ||||||||||||||||
CIMI Projects: CIMI Management Group | CIMI MG Approval Date | N/A | ||||||||||||||
CDA Projects: CDA Management Group | CDA MG Approval Date | N/A | ||||||||||||||
FHIR Projects: FHIR Management Group | FMG Approval Date | 2019-01-23 | ||||||||||||||
V2/Publishing Projects: V2 Management Group | V2 MG Approval Date | N/A | ||||||||||||||
US Realm Projects: US Realm Steering Committee Approval | USRSC Approval Date | 2019-01-25 | ||||||||||||||
Affiliate Specific Projects: Affiliate Approval Date | Affiliate Approval Date | N/A | ||||||||||||||
Submit PSS to Steering Division after all of the above approvals are received | ||||||||||||||||
Steering Division (of Primary Sponsor WG) Approval Date: | SD Approval Date | 2019-02-04 | ||||||||||||||
| ||||||||||||||||
ARB and Steering Division approval may be in parallel | ||||||||||||||||
Architectural Review Board Approval Date: (required for externally developed content) | ARB Approval Date | N/A | ||||||||||||||
TSC Approval | ||||||||||||||||
If applicable, TSC has received a Joint Copyright/Distribution Agreement (containing the verbiage outlined within the SOU), |
| |||||||||||||||
Technical Steering Committee Approval Date: | TSC Approval Date |